Experic

Executive Summary

Experic is a privately held Contract Development and Manufacturing Organization (CDMO) founded in 2016, specializing in complex powder handling and dry powder inhalation (DPI) drug products. The company operates cGMP-compliant facilities in Cranbury, New Jersey, USA, and Kilbeggan, Ireland, offering bespoke development, manufacturing, and clinical trial supply services. With a focus on high-barrier DPI technologies, Experic serves a niche but growing segment of the pharmaceutical industry as inhaled therapies gain traction for respiratory and systemic conditions. The company's dual-continent footprint positions it well to support global clinical trials and commercial manufacturing demands. Despite limited public information on financials or pipeline, Experic's specialized expertise and cleanroom infrastructure suggest a stable, if low-profile, market presence. The company's growth hinges on capturing additional CDMO contracts and expanding its capacity to meet rising demand for inhaled drug products.

Upcoming Catalysts (preview)

• Q3 2026Capacity Expansion at Kilbeggan Facility70% success
• Q4 2026New DPI Platform Partnership or Licensing Deal50% success
• Q1 2027Major CDMO Contract Win for Clinical Trial Supply60% success